Patriot Investment Management Group Inc. Cuts Position in iShares Biotechnology ETF (NASDAQ:IBB)

Patriot Investment Management Group Inc. decreased its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 1.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,162 shares of the financial services provider’s stock after selling 185 shares during the period. Patriot Investment Management Group Inc.’s holdings in iShares Biotechnology ETF were worth $1,480,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Future Financial Wealth Managment LLC acquired a new stake in shares of iShares Biotechnology ETF during the 1st quarter valued at approximately $27,000. Bbjs Financial Advisors LLC purchased a new position in iShares Biotechnology ETF in the 2nd quarter valued at approximately $31,000. Pacifica Partners Inc. increased its stake in iShares Biotechnology ETF by 118.2% in the 1st quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock valued at $33,000 after purchasing an additional 130 shares in the last quarter. Mather Group LLC. acquired a new position in iShares Biotechnology ETF during the first quarter worth $57,000. Finally, Chris Bulman Inc purchased a new stake in iShares Biotechnology ETF during the second quarter worth $64,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $145.59 on Monday. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $150.57. The stock’s fifty day moving average is $145.12 and its two-hundred day moving average is $139.38.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.